Microbot Medical Inc. 8-K

What Happened

• On February 24, 2026, Microbot Medical Inc. (MBOT) issued a press release announcing that Tampa General Hospital has become the first health system in Florida to adopt the LIBERTY® Endovascular Robotic System. The release was furnished under Regulation FD and included as Exhibit 99.1 to the Company’s Form 8-K.

Key Details

• Date of announcement: February 24, 2026 (Form 8-K filing date).
• Hospital: Tampa General Hospital — identified as the first health system in Florida to adopt the LIBERTY system.
• Product: LIBERTY® Endovascular Robotic System, following the Company’s recent FDA 510(k) clearance.
• Filing: Announcement furnished on Form 8-K as Exhibit 99.1 (Item 7.01 disclosure).

Why It Matters

• The filing documents a commercial adoption milestone for Microbot Medical following FDA 510(k) clearance, showing the company moving from regulatory approval toward clinical and hospital deployment. For investors, this is a factual update on product rollout and potential market traction; the company furnished the announcement under Regulation FD to ensure broad public disclosure.